Latest filing published 19 Nov 2021 for Flexion Therapeutics Inc, €775k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam Muzikant: trading record in brief
This profile gathers the share dealings of Adam Muzikant in Flexion Therapeutics Inc, where the filings describe the role as senior executive. In total, 5 filings cover trades dated from 5 January 2021 to 19 November 2021.
No open-market purchase appears, only 2 sales worth €47k. Other entries cover 2 share grants.
Most recently, on 19 November 2021, the filings show a transaction worth €775k in Flexion Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Adam Muzikant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 103,666 shares@ US$8.5097.0% of flowCommon StockSEC:0001209191-21-065711:0
- 1,870 shares@ US$6.451.3% of flowCommon StockSEC:0001209191-21-047503:0
- 2,081 shares@ US$7.781.7% of flowCommon StockSEC:0001209191-21-043524:0
3 of 3 declarations